Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Cells of the Adaptive Immune Response

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

Introduction to Lymphatic and Immune System

Introduction to Lymphatic and Immune System

Immunity is a crucial biological concept about our body's inherent capacity to prevent infections and diseases. A complex network of cells and tissues collectively known as the immune system facilitates this natural defense mechanism. The immune system plays an integral role in maintaining our health and well-being, shielding us from potential health threats.
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are born...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia.

Frontiers in genetics·2023

Same author

Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster.

Blood cancer journal·2022

Same author

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

Blood·2022

Same author

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies.

JCO global oncology·2022

Same author

T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma.

The New England journal of medicine·2022

Same author

The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.

Nature communications·2022

Same journal

Geographical Pattern of Testicular Cancer Points to Maternal Exposures Behind Increasing Incidence.

International journal of cancer·2026

Same journal

High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy.

International journal of cancer·2026

Same journal

Epigenetic Dysregulation of Somatostatin Receptors (SSTR) 1-5 and Therapeutic Implications in Neuroendocrine and Non-Neuroendocrine Malignancies.

International journal of cancer·2026

Same journal

Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients.

International journal of cancer·2026

Same journal

MET Expression in Upper Gastrointestinal Adenocarcinoma: Prevalence, Prognostic Impact, and Implications for Anti-MET Antibody-Drug Conjugate Therapy.

International journal of cancer·2026

Same journal

Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification.

International journal of cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

Autoimmunity and lymphomagenesis.

Lynn R Goldin¹, Ola Landgren

¹Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892-7236, USA. goldinl@mail.nih.gov

International Journal of Cancer

|December 18, 2008

Summary

This summary is machine-generated.

Autoimmune diseases are linked to lymphomas, including non-Hodgkin lymphoma and myeloma. Research reviews population studies on autoimmune history and lymphoma development, exploring underlying mechanisms.

More Related Videos

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8⁺ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 27, 2026

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8⁺ T Cells During Tumorigenesis

Published on: January 26, 2024

Area of Science:

Immunology
Oncology
Epidemiology

Background:

Established links between autoimmunity and lymphoma for over 50 years.
Recent decades have focused on population-level data to investigate these associations.
Studies assess autoimmune history in lymphoma/myeloma patients and lymphoma risk in autoimmune disease cohorts.

Purpose of the Study:

Review population-based association studies on autoimmunity and lymphoma.
Discuss revealed mechanisms and pathways underlying both conditions.
Outline future research directions combining population and molecular studies.

Main Methods:

Case-control studies assessing autoimmune history in lymphoma (primarily non-Hodgkin lymphoma) and myeloma patients.
Cohort studies following patients with autoimmune diseases for lymphoma and multiple myeloma development.
Review of published association studies using Scandinavian and US Veterans data.

Main Results:

Population studies confirm significant associations between specific autoimmune diseases and subsequent lymphoma risk.
Findings suggest shared immunological pathways contributing to both autoimmunity and lymphomagenesis.
Data indicate increased risk for specific lymphoma subtypes in patients with certain autoimmune conditions.

Conclusions:

The interplay between autoimmunity and lymphoma is complex, involving shared biological mechanisms.
Population studies provide valuable insights into etiological pathways.
Future research should integrate population data with molecular analyses for a comprehensive understanding.